| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |